Todd Hobbs
Edison Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Education, Medication Adherence and Compliance
Most-Cited Works
- → Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system(2017)222 cited
- → Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system(2015)131 cited
- → Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus(2020)101 cited
- → Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set(2018)85 cited
- → Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association(2020)85 cited
- → Persistence of newer anti-obesity medications in a real-world setting(2018)67 cited
- → The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States(2019)64 cited
- → The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model(2020)54 cited
- → Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease(2018)51 cited
- → Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes(2017)46 cited